Jim Cloar is listed as a director on 2 SEC Form D filings by 1 issuer between Jun 2024 and Apr 2026: Marrow Access Technologies, Inc. (Eden Prairie, MN — other health care — 2024–2026; $515K reported sold to 18 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Dan Fisher (2 shared filings), Jason Koh (2 shared filings), Joseph Saladino (2 shared filings), Paul Verrastro (2 shared filings) and Kevin Foley (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jim. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Jim Cloar and found 3 differences, 1 worth asking the sponsor about: Form D filed 83 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.